The recently approved vaccines for respiratory syncytial virus have already been linked to deaths and serious injuries, but US health officials continue to recommend them as "Safe and effective."
Recently there have been reports about a possible link to the RSV vaccine and a rare and serious nervous system condition Guillain-Barré syndrome.
The Defender reports: Reported cases include several instances of severe adverse events in newborns, including the death of a 27-day-old baby who was wrongly administered the vaccine, and in pregnant women and people in age groups for which the RSV vaccines were not approved.
Members of the CDC's Advisory Committee on Immunization Practices presented the data on deaths and adverse events related to the RSV vaccines at a Feb. 29 meeting.
Brian Hooker, Ph.D., chief scientific officer for Children's Health Defense, said "34 deaths in 10 months should be sufficient to pull the RSV vaccines from the market. But the FDA will not do that - nor will there be full investigations regarding these deaths."
According to the CDC data presented at the Feb. 29 ACIP meeting, of the 34 deaths reported as of Feb. 16 following RSV vaccination, 22 were linked to Arexvy and nine to Abrysvo.
According to Albert Benavides, founder of VAERSAware.com, three more "Hidden" deaths reported after RSV vaccines are listed in VAERS, but the vaccine name is unlabeled.
No comments:
Post a Comment